This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,345.79 firm fixed price delivery order is for the supply of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. This award is considered a "child" contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 1/22/25, 9:15 AM